$ARDX SCRIPT update from StockTwits poster M_Of_E below. (He is conscientious & balanced..a measured approach). My interpretation and dumbing it down a bit for those new here: TRx is total scripts. NRx is new starts. RRx is refills. Total patients on a four-week roll is the installed base. For Ibsrela, the poster is saying the franchise is still adding people. Four-week TRx was a solid gain 💯🥳 even if it wasn’t a record week, and that pushed the four-week patient count to a new high. 📈 Refills looked good. 👍 New scripts were only okay after last week’s blowout. 😌 That mix is exactly the Q2 story Ardelyx already told: Demand and refills are holding up, new paid starts are the sticky part. That’s why they cut 2026 Ibsrela guidance from $410m to $430m down to $350m to $37
View on X ↗